ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public

Two RNA biotechs, ADARx Pharmaceuticals and City Therapeutics, are taking advantage of the IPO frenzy, which has led to a total of 27 newly public biotechs so far this year.